Blood pressure and cardiovascular mortality in dialysis patients with left ventricular systolic dysfunction

Attilio Losito1, Lucia Del Vecchio, Goffredo Del Rosso

  • 1Ospedale Santa Maria Della Misericordia, Perugia, Italy.

Insights

Blood pressure (BP) before and after hemodialysis impacts cardiovascular mortality in patients with heart failure. Higher predialysis BP and lower postdialysis BP are linked to better survival in these high-risk patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Research

Background:

  • Patients on chronic hemodialysis exhibit high heart failure prevalence and poor prognosis.
  • The specific impact of blood pressure (BP) on cardiovascular (CV) mortality in this population remains unclear.

Purpose of the Study:

  • To investigate the association between pre- and postdialysis BP measurements and CV and all-cause mortality.
  • To identify BP parameters predictive of mortality in dialysis patients with reduced left ventricular (LV) ejection fraction.

Main Methods:

  • A follow-up study involving 557 dialysis patients with LV ejection fraction <50%.
  • Cox multivariable analysis was used to build a predictive model for CV mortality.
  • Analysis included age, dialysis duration, diabetes, serum albumin, dialysis technique, and predialysis and postdialysis mean arterial pressure (MAP).

Main Results:

  • During follow-up (mean 21.6 months), 179 deaths occurred, with 98 from CV causes.
  • Predialysis MAP showed an inverse relationship with CV mortality (HR=0.978), while postdialysis MAP had a direct relationship (HR=1.035).
  • Predialysis and postdialysis systolic BP, but not diastolic BP, predicted CV mortality. Predialysis MAP correlated with BMI, and postdialysis MAP with weight loss during dialysis.

Conclusions:

  • CV mortality in dialysis patients with LV dysfunction is complexly associated with both pre- and postdialysis BP.
  • Nutritional status and fluid management during dialysis may influence this relationship.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.3K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.5K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
2.0K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
642